Valuation: Celltrion, Inc.

Market Cap 47,400B 35.56B 32.43B 29.99B 27.06B 50.97B 3,323B 52.97B 362B 143B 1,794B 133B 131B 5,664B P/E 2026 *
35.1x
P/E 2027 * 26.1x
Enterprise Value 49.97B 37.49M 34.19M 31.61M 28.53M 53.72M 3.5B 55.84M 382M 151M 1.89B 141M 138M 5.97B EV / Sales 2026 *
8.68x
EV / Sales 2027 * 7.46x
Free-Float
58.01%
Yield 2026 *
0.37%
Yield 2027 * 0.39%
1 day-2.58%
1 week+0.24%
Current month+8.30%
1 month+6.96%
3 months+6.14%
6 months+18.93%
Current year+20.37%
1 week 206,500
Extreme 206500.00000000
219,000
1 month 187,500
Extreme 187500
219,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 137,362.64
Extreme 137362.63736
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-2.58%+0.24%+18.54%+41.28% 36.44B
-1.34%-3.09%+56.10%+68.83% 66.37B
+0.59%-1.83%+8.98%+90.01% 58.86B
+0.54%+0.45%+25.96%+87.77% 55.22B
-2.34%-3.90%+10.90%+115.97% 47.21B
+0.09%-6.08%+18.67%+25.90% 42.45B
-1.76%-11.56%+126.44%+649.27% 35.19B
-0.17%-1.83%+82.46%+57.69% 32.66B
-1.69%-0.79%-40.58%+382.68% 26.73B
-0.81%-9.41%+38.72%-7.75% 24.22B
Average -0.95%-3.99%+34.62%+151.17% 43B
Weighted average by Cap. -0.84%-3.69%+34.47%+135.34%

Financials

2026 *2027 *
Net sales 5,755B 4.32B 3.94B 3.64B 3.29B 6.19B 403B 6.43B 43.97B 17.38B 218B 16.2B 15.86B 688B 6,605B 4.95B 4.52B 4.18B 3.77B 7.1B 463B 7.38B 50.46B 19.95B 250B 18.59B 18.2B 789B
Net income 1,379B 1.03B 944M 873M 788M 1.48B 96.7B 1.54B 10.54B 4.17B 52.2B 3.88B 3.8B 165B 1,835B 1.38B 1.26B 1.16B 1.05B 1.97B 129B 2.05B 14.02B 5.54B 69.43B 5.16B 5.06B 219B
Net Debt 2,566B 1.92B 1.76B 1.62B 1.46B 2.76B 180B 2.87B 19.6B 7.75B 97.08B 7.22B 7.07B 307B 1,849B 1.39B 1.27B 1.17B 1.06B 1.99B 130B 2.07B 14.13B 5.58B 69.97B 5.2B 5.1B 221B
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-11-18 ₩207,500.00 -2.58% 437,448
26-11-17 ₩213,000.00 -0.70% 350,466
26-11-16 ₩214,500.00 +0.23% 352,775
26-11-13 ₩214,000.00 +2.15% 436,767
26-11-12 ₩209,500.00 +1.21% 569,041
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
207,500.00KRW
Average target price
278,545.45KRW
Spread / Average Target
+34.24%
  1. Stock Market
  2. Stocks
  3. A068270 Stock